We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Case Study · May 03, 2018

Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases When Adjusting for Patient Characteristics and Comorbidities

Journal of the American Heart Association

 

Additional Info

Journal of the American Heart Association
Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities
J Am Heart Assoc 2018 Apr 21;7(9)e008074, LA Polgreen, BN Riedle, JE Cavanaugh, S Girotra, B London, MC Schroeder, PM Polgreen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading